Crush The Market

undefined Logo

Vertex Pharmaceuticals Incorporated

312.22 USD

-2.83%

Add To Watchlist

Page 1 of 26

2021-1996

Currency in USD2021
PeriodFY
Revenue7.57 Billion
Cost Of Revenue904.20 Million
Gross Profit6.67 Billion
Gross Profit Ratio0.88
Research And Development Expenses3.05 Billion
General And Administrative Expenses0.00
Selling And Marketing Expenses0.00
Selling General And Administrative Expenses840.10 Million
Other Expenses0.00
Operating Expenses3.89 Billion
Cost And Expenses4.80 Billion
Interest Income4.90 Million
Interest Expense61.50 Million
Depreciation And Amortization125.60 Million
Ebitda2.92 Billion
Ebitdaratio0.39
Operating Income2.78 Billion
Operating Income Ratio0.37
Total Other Income Expenses Net-51.7 Million
Income Before Tax2.73 Billion
Income Before Tax Ratio0.36
Income Tax Expense388.30 Million
Net Income2.34 Billion
Net Income Ratio0.31
Eps9.09
Epsdiluted9.01
Weighted Average Shs Out257.70 Million
Weighted Average Shs Out Dil259.90 Million
Linkhttps://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm
Final Linkhttps://www.sec.gov/Archives/edgar/data/875320/000087532022000007/vrtx-20211231.htm

Crush The Market

We Use Cookies